Ovoca Bio | OVG - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
ALKERMES USD 264.59M 77.4M 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Great Western Mining Corporation EUR 486.58K 43.28K 2025-06
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 173M 135M 2026-03
Organon & Co USD 424M 9M 2026-03
Ovoca Bio EUR 632K 2.33M 2025-06
Revvity USD 253.88M 2.15M 2026-03
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 928.8M 101.9M 2026-03
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03